Cu Seng Kiu
CIK: 0001891617
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Kiu Cu Seng
Kiu Cu Seng (SEC CIK 0001891617) files insider reports with the SEC as Officer of ARC Group Acquisition I Corp. (ARCL) and CFO and Secretary of Cyclacel Pharmaceuticals, Inc. (CYCC).
Signal8 holds 3 ownership filings by Kiu Cu Seng (2 Form 3, 1 Form 4), filed between Feb 28, 2025 and May 1, 2026. Those filings report 1 transaction, the latest on Nov 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kiu Cu Seng's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by Kiu Cu Seng
- Nov 12, 2025: Grant or award of BGMS shares (Form 4, code A).
Other insiders filing for ARC Group Acquisition I Corp. (ARCL)
- MFH 2, LLC, 10% Owner
- Pappas Soon Ping, Director
- Hanna Ian Lee
- Laurduraj Inigo Angel, Director
- Nair Krishnan Satis Waran, Director
- Doris Wong Sing Ee